| Mutant EGFR inhibitor |
N-[5-[[5-氯-4-(1H-吲哚-3-基)-2-嘧啶基]氨基]-2-[[2-(二甲基氨基)乙基]甲基氨基]-4-甲氧基苯基]-2-丙烯酰胺 |
1421373-62-7 |
| 1alpha-Hydroxy VD4 |
1ALPHA-羟基维生素 D4 |
143032-85-3 |
| GSK2838232 |
GSK2838232 |
1443461-21-9 |
| IDE 2 |
IDE-2;IDE 2;IDE2 |
1136466-93-7 |
| AC-IEPD-AFC |
AC-ILE-GLU-PRO-ASP-AFC |
1135417-31-0 |
| ADRENIC ACID |
廿二碳四烯酸 |
28874-58-0 |
| AC-LEU-GLU-THR-ASP-AFC |
AC-LEU-GLU-THR-ASP-AFC |
210345-02-1 |
| SHA 68 |
SHA 68 |
847553-89-3 |
| ALPHA-(TRICHLOROMETHYL)-4-PYRIDINEETHANOL |
Α-(三氯甲基)-4-吡啶乙醇 |
10129-56-3 |
| 4′-[[2,3-Dimethyl-5-[[[(1S)-1-(4-nitrophenyl)ethyl]amino]carbonyl]-1H-indol-1-yl]methyl]- [1,1′-Biphenyl]-2-carboxylic acid |
4′-[[2,3-Dimethyl-5-[[[(1S)-1-(4-nitrophenyl)ethyl]amino]carbonyl]-1H-indol-1-yl]methyl]- [1,1′-Biphenyl]-2-carboxylic acid |
1338259-05-4 |
| AMINO[(3,4-DICHLOROBENZYL)SULFANYL]METHANIMINIUM CHLORIDE |
AMINO[(3,4-DICHLOROBENZYL)SULFANYL]METHANIMINIUM CHLORIDE |
22816-60-0 |
| ALEXIDINE DIHYDROCHLORIDE |
己联双辛胍 |
22573-93-9 |
| N-(12-Cyanindolizino[2,3-b]quinoxalin-2-yl)-2-thiophenecarboxaMide |
TOPK抑制剂(HI-TOPK-032) |
487020-03-1 |
| (OC-6-44)-Tricarbonylchloro(glycinato)ruthenium |
(OC-6-44)-三羰基氯(甘氨酸基)钌 |
475473-26-8 |
| NSC-41589 |
化合物NSC-41589 |
6310-41-4 |
| 4-AMINO-5-CYANO-7-(BETA-D-RIBOFURANOSYL)PYRROLO[2,3-D]PYRIMIDINE |
丰加霉素 |
606-58-6 |
| 17ALPHA,20BETA-DIHYDROXY-4-PREGNEN-3-ONE |
4-孕烷-17Α,20Β-二醇-3-酮 |
1662-06-2 |
| N-(3-Azidopropyl)biotinaMide |
生物素-叠氮 |
908007-17-0 |
| ALPHA-D-GALACTOSE-1-PHOSPHATE DIPOTASSIUM SALT DIHYDRATE |
阿尔法-D-半乳糖 1-磷酸二钾盐五水合物 |
19046-60-7 |
| 2 - (4 - Methylphenyl) - 1,2 - benzisothiazol - 3(2H)-one |
2 - (4 - Methylphenyl) - 1,2 - benzisothiazol - 3(2H)-one |
2514-30-9 |
